News About: Pharm. Industry
Drug makers eye pharmacy market
To prepare for government-mandated cuts in drug prices, major Korean drug makers are jumping into the pharmacy business of selling over-the-counter drugs and functional health foods to avoid losses.
Dong-A Pharma h...
‘SKY’ universities alumni top 41%
According to a recent report, 33 of 80 chief executive officers working for listed pharmaceutical companies graduated from the three most prestigious universities: Seoul National University, Korea University and Yonse...
Drug firms’ eligibility for innovative pharmaceutical firms to be assessed
The Ministry of Health and Welfare and the Korea Health Industry Development Institute are expected to step in and designate 50 innovative pharmaceutical firms as the applications begins from today and last until May ...
Controversy mounts over establishment of new organization
Tension is escalating between old and new executives of the Korea Pharmaceutical Manufacturers Association over the recent announcement of 11 medium- and large-sized companies that they will form a new organization in...
Compensation of returned goods headache to wholesalers
Pharmaceutical wholesales have found it increasingly difficult to deal with returned goods due to major drug makers’ refusal to compensate up to 30 percent of the returned medicines from pharmacies.
“Some leading c...
Novartis Korea sales rise, profits drop
Novartis Korea, a Korean unit of Novartis Group, said yesterday it posted 478.7 billion won in revenue last year, up 9.86 percent a year earlier, but the company’s operating profit dipped more than 24 percent year-on-...
KPMA chief seeking cohesiveness of organization
For decades, the Korea Pharmaceutical Manufacturers Association (KPMA) has been a solid advocate of the domestic drug makers as the principal business lobby.
While it is trying to raise its voice public sentiment ...
12 blockbuster drugs owned by ‘big three’Korea’s so-called ‘big three’ drug makers - Dong-A Pharmaceutical, Daewoong Pharmaceutical and Yuhan Corp. - released 12 blockbuster drugs generating more than 30 billion won of...
|
Ilsung re-strengthening strategic alliance with GSK Korea
Ilsung Pharm is actively re-seeking strategic alliances with a Korean unit of GlaxoSmilthKline (GSK) over Augmentin, a penicillin antibiotic for treatment of various injections, using its strong sales and marketing fo...
30 drugmakers to establish new pharmaceutical body
A total of 11 medium- and large-sized pharmaceutical firms decided to set up a new research-oriented body early May, raising a concern from the Korea Pharmaceutical Manufacturers Association (KPMA).
The participant...
